เอกสารอ้างอิง
1. กรมควบคุมโรค. กองโรคป้องกันด้วยวัคซีน. ตำราวัคซีน และการสร้างเสริมภูมิคุ้มกันโรค ปี 2562. กรุงเทพฯ: บริษัท
เวิร์คพริ้นติ้ง จำกัด; 2562 หน้า 209-13, 269-70.
2. Kastrup EK. Drug facts and comparisons. St. Louis: Wolters Kluwer; 2017: 3262-7.
3. McEvoy GK. AHFS drug information. Bethesda: American Society of Health-System
Pharmacists, Inc; 2018: 3442, 3450.
4. Bhandari P, Brett C, Batool A, Sapra A. Hepatitis A Vaccine. In: StatPearls [Internet].
Treasure Island (FL): StatPearls Publishing; 2020 Jan;14(3):121-4. PMID: 32119491.
5. Li H, Zhang XS, An J. [Evaluation on the effect of immunization and safety of live attenuated and inactivated hepatitis A vaccine in China]. Zhonghua Liu Xing Bing Xue Za Zhi. 2013 Jan;34(1):24-7. Chinese. PMID: 23648244.
6. Zheng H, Chen Y, Wang F, Gong X, Wu Z, Miao N, Zhang X, Li H, Chen C, Hou X, Cui F, Wang H.
Comparing live attenuated and inactivated hepatitis A vaccines: an immunogenicity study after
one single dose. Vaccine. 2011 Nov 8;29(48):9098-103.
7. Ma F, Yang J, Kang G, Sun Q, Lu P, Zhao Y, Wang Z, Luo J, Wang Z. Comparison of the safety and
immunogenicity of live attenuated and inactivated hepatitis A vaccine in healthy Chinese
children aged 18 months to 16 years: results from a randomized, parallel controlled, phase
IV study. Clin Microbiol Infect. 2016 Sep;22(9):811.e9-811.e15.
8. Xu ZY, Wang XY. Live attenuated hepatitis A vaccines developed in China. Hum Vaccin Immunother.
2014;10(3):659-66.
9. Letson GW, Shapiro CN, Kuehn D, Gardea C, Welty TK, Krause DS, Lambert SB, Margolis HS. Effect of
maternal antibody on immunogenicity of hepatitis A vaccine in infants. J Pediatr. 2004
Mar;144(3):327-32. doi: 10.1016/j.jpeds.2003.11.030. PMID: 15001936.